KCM
IMMU

Karp Capital Management’s Immunomedics Inc IMMU Stock Holding History

Karp Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,300
Closed -$33K – 418
2018
Q4 		$33K Buy
+2,300
New +$45.7K 0.02% 175
2015
Q4 		– Sell
-1,500
Closed -$3K – 309
2015
Q3 		$3K Hold
1,500
– – ﹤0.01% 316
2015
Q2 		$6K Hold
1,500
– – ﹤0.01% 321
2015
Q1 		$6K Hold
1,500
– – ﹤0.01% 301
2014
Q4 		$7K Buy
+1,500
New +$5.93K 0.01% 295

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Karp Capital Management's IMMU Position: Q1 2019 in Review

Karp Capital Management sold out of Immunomedics Inc (IMMU) in Q1 2019, closing a stake of 2,300 shares — an estimated $33K sold.

Karp Capital Management first reported a position in IMMU in Q4 2014 and held it in 5 quarters. The position peaked at $33K in Q4 2018. 204 funds tracked by Wall St. Rank hold IMMU as of Q1 2019.

  • Karp Capital Management reported no remaining Immunomedics Inc position as of Q1 2019 after selling out during the quarter.
  • Karp Capital Management sold 2,300 Immunomedics Inc shares in Q1 2019, an estimated $33K.
  • Karp Capital Management first reported a position in Immunomedics Inc in Q4 2014 and held it in 5 quarters.
  • Karp Capital Management's Immunomedics Inc position peaked at $33K in Q4 2018.
  • 204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2019.

Based on Karp Capital Management's 13F filing for Q1 2019, filed 7 May 2019.